Genisphere LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genisphere LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10353
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline products in the areas of oncology and ocular. Genisphere offers GL 249, a preventative treatment of Posterior Capsule Opacification (PCO), a vision impairing disease that occurs in adults and children following cataract surgery. It also develops GL 233 which is used in the treatment of ovarian cancer. The company’s design stage product pipeline includes GS-2A3, GL-23X, GL-246, and GL-238 intended for the treatment of ovarian cancer, pancreatic cancer, triple negative breast cancer and glioblastoma respectively. Genisphere is headquartered in Hatfield, Pennsylvania, the US.

Genisphere LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genisphere LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genisphere LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genisphere LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genisphere LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genisphere LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genisphere LLC, Medical Equipment, Deal Details 10
Venture Financing 10
Genisphere Raises USD1.5 Million in Venture Financing 10
Genisphere Raises USD7 Million in Financing 11
Genisphere Raises USD2 Million in Venture Financing 12
Partnerships 13
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 13
MedImmune Enters into Agreement with Genisphere 14
Genisphere Enters Into Co-Development Agreement With Lankenau Institute for Medical Research 15
Genisphere LLC – Key Competitors 16
Genisphere LLC – Key Employees 17
Genisphere LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Genisphere LLC, Medical Equipment, Key Facts 2
Genisphere LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genisphere LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genisphere LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genisphere LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genisphere LLC, Deals By Market, 2012 to YTD 2018 8
Genisphere LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genisphere Raises USD1.5 Million in Venture Financing 10
Genisphere Raises USD7 Million in Financing 11
Genisphere Raises USD2 Million in Venture Financing 12
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 13
MedImmune Enters into Agreement with Genisphere 14
Genisphere Enters Into Co-Development Agreement With Lankenau Institute for Medical Research 15
Genisphere LLC, Key Competitors 16
Genisphere LLC, Key Employees 17

List of Figures
Genisphere LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genisphere LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genisphere LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genisphere LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genisphere LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genisphere LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genisphere LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genisphere LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cardif Lux Vie S.A.:企業の戦略・SWOT・財務情報
    Cardif Lux Vie S.A. - Strategy, SWOT and Corporate Finance Report Summary Cardif Lux Vie S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • LeMaitre Vascular Inc (LMAT)-医療機器分野:企業M&A・提携分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Eiger BioPharmaceuticals Inc (EIGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Cadent Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Cadent Therapeutics (Cadent), formerly Luc Therapeutics Inc, is a precision neuroscience company that offers medicines for serious neurological diseases. The company's products comprise NR2B positive allosteric modulators, NR2A negative allosteric modulators and NR2B negative allosteric modu …
  • GEO Specialty Chemicals Inc:企業の戦略的SWOT分析
    GEO Specialty Chemicals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Corby Spirit and Wine Limited:企業の戦略・SWOT・財務情報
    Corby Spirit and Wine Limited - Strategy, SWOT and Corporate Finance Report Summary Corby Spirit and Wine Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cosmo Oil Co., Ltd.:企業の戦略・SWOT・財務分析
    Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cosmo Oil Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ValiRx Plc (VAL)-医療機器分野:企業M&A・提携分析
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • JAFCO Co., Ltd.:企業のM&A・事業提携・投資動向
    JAFCO Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JAFCO Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Experian plc:企業の戦略・SWOT・財務分析
    Experian plc - Strategy, SWOT and Corporate Finance Report Summary Experian plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Petroleum & Chemical Corporation (600028)-エネルギー分野:企業M&A・提携分析
    Summary China Petroleum & Chemical Corporation (Sinopec), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and producti …
  • Public Bank Berhad:戦略・SWOT・企業財務分析
    Public Bank Berhad - Strategy, SWOT and Corporate Finance Report Summary Public Bank Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GFI Informatique:企業の戦略・SWOT・財務分析
    GFI Informatique - Strategy, SWOT and Corporate Finance Report Summary GFI Informatique - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dubai Electricity and Water Authority-エネルギー分野:企業M&A・提携分析
    Summary Dubai Electricity and Water Authority (DEWA) generates, transmits and distributes electricity; and conducts desalination of water. DEWA’s power plants included Jebel Ali Power Station D, E, G, K, L Phase I, L Phase II, and M; Aweer Power Station H Phase I, Phase II, and Phase III. The desali …
  • Valeura Energy Inc (VLE):石油・ガス:M&Aディール及び事業提携情報
    Summary Valeura Energy Inc (Valeura) is an upstream oil and gas company that explores for, develops and produces oil and natural gas. It operates mainly in the Thrace Basin in the northwest of Turkey pursuing conventional shallow natural gas, unconventional tight gas and a basin-centered gas accumul …
  • Yantai Dongcheng Pharmaceutical Group Co Ltd (002675):製薬・医療:M&Aディール及び事業提携情報
    Summary Yantai Dongcheng Pharmaceutical Group Co Ltd (Yantai Dongcheng Pharma), formerly Yantai Dongcheng Biochemicals Co Ltd, is a developer, manufacturer, and marketer of biochemical API, chemical synthetic drugs, and Chinese medicines. The company offers its products under categories including he …
  • Intuitive Surgical Inc (ISRG)-医療機器分野:企業M&A・提携分析
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆